×




Amgen Inc.: Pursuing Innovation and Imitation? (A) Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Amgen Inc.: Pursuing Innovation and Imitation? (A) case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Amgen Inc.: Pursuing Innovation and Imitation? (A) case study is a Harvard Business School (HBR) case study written by Ian W Mackenzie. The Amgen Inc.: Pursuing Innovation and Imitation? (A) (referred as “Amgen Bs” from here on) case study provides evaluation & decision scenario in field of Strategy & Execution. It also touches upon business topics such as - Value proposition, .

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Amgen Inc.: Pursuing Innovation and Imitation? (A) Case Study


Set in 2009, the (A) case explores whether Amgen, a leading innovator of biotech-based drugs, should enter the emerging business of biosimilars (BS), which are essentially 'me-too' products. There appear to be sound reasons to explore this related diversification: innovation is getting harder, regulators are intent on encouraging BS, and Amgen needs renewed growth. But the possibility sparked a strong negative reaction within Amgen, not least because it contravened Amgen's mission. Internal debate was exacerbated by the presence of considerable uncertainty over the regulatory requirements for BS development and how difficult it would be to develop a BS. Some felt it played to Amgen's strengths, others felt that Amgen lacked critical capabilities. Many felt there was simply no need for any change in strategy at all. To navigate through this morass, Amgen needed clear strategic thinking. Amgen set out to see if an objective business case for entry could be built. This involved settling on a set of most likely assumptions, quantitatively estimating likely revenue and profitability, testing out sensitivity to assumptions using scenarios, and assessing the main risks of entry and of staying out. The analysis provided strong support for entry subject to the key assumptions. The (A) case also invites students to think through how CEO Kevin Sharer should handle a positive entry decision given the divided opinions across the senior management team.


Case Authors : Ian W Mackenzie

Topic : Strategy & Execution

Related Areas :




Calculating Net Present Value (NPV) at 6% for Amgen Inc.: Pursuing Innovation and Imitation? (A) Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10004863) -10004863 - -
Year 1 3470584 -6534279 3470584 0.9434 3274136
Year 2 3976602 -2557677 7447186 0.89 3539162
Year 3 3941559 1383882 11388745 0.8396 3309409
Year 4 3241871 4625753 14630616 0.7921 2567865
TOTAL 14630616 12690572




The Net Present Value at 6% discount rate is 2685709

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Net Present Value
2. Profitability Index
3. Internal Rate of Return
4. Payback Period

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Amgen Bs have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Amgen Bs shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Amgen Inc.: Pursuing Innovation and Imitation? (A)

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Strategy & Execution Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Amgen Bs often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Amgen Bs needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10004863) -10004863 - -
Year 1 3470584 -6534279 3470584 0.8696 3017899
Year 2 3976602 -2557677 7447186 0.7561 3006882
Year 3 3941559 1383882 11388745 0.6575 2591639
Year 4 3241871 4625753 14630616 0.5718 1853550
TOTAL 10469971


The Net NPV after 4 years is 465108

(10469971 - 10004863 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10004863) -10004863 - -
Year 1 3470584 -6534279 3470584 0.8333 2892153
Year 2 3976602 -2557677 7447186 0.6944 2761529
Year 3 3941559 1383882 11388745 0.5787 2280995
Year 4 3241871 4625753 14630616 0.4823 1563402
TOTAL 9498080


The Net NPV after 4 years is -506783

At 20% discount rate the NPV is negative (9498080 - 10004863 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Amgen Bs to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Amgen Bs has a NPV value higher than Zero then finance managers at Amgen Bs can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Amgen Bs, then the stock price of the Amgen Bs should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Amgen Bs should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What will be a multi year spillover effect of various taxation regulations.

Understanding of risks involved in the project.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What can impact the cash flow of the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Amgen Inc.: Pursuing Innovation and Imitation? (A)

References & Further Readings

Ian W Mackenzie (2018), "Amgen Inc.: Pursuing Innovation and Imitation? (A) Harvard Business Review Case Study. Published by HBR Publications.


Volvik SWOT Analysis / TOWS Matrix

Consumer Cyclical , Recreational Products


Itec SWOT Analysis / TOWS Matrix

Basic Materials , Iron & Steel


Lotte Confectionery SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing


Grindwell Norton Ltd SWOT Analysis / TOWS Matrix

Capital Goods , Constr. - Supplies & Fixtures


T.Kawabe & SWOT Analysis / TOWS Matrix

Consumer Cyclical , Apparel/Accessories


Federal Mogul Goetze SWOT Analysis / TOWS Matrix

Consumer Cyclical , Auto & Truck Parts


Allianz Malaysia SWOT Analysis / TOWS Matrix

Financial , Insurance (Prop. & Casualty)


Sansuy SWOT Analysis / TOWS Matrix

Basic Materials , Chemicals - Plastics & Rubber